WallStreetZenWallStreetZen

NASDAQ: AFJK
Aimei Health Technology Co Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Aimei Health Technology Co earnings were $920.5k for the trailing 12 months ending Mar 31, 2026, with -30.4% growth year over year. The latest AFJK earnings report on Mar 31, 2026 announced Q1 2026 earnings of $45.4k, down 53.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AFJK reported annual earnings of $1.1M, with -58.5% growth. The next AFJK earnings date is Aug 12, 2026.

AFJK past earnings growth

How has AFJK's earnings growth performed historically?

Company
-30.43%
Industry
1.84%
Market
85.49%
AFJK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
AFJK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

AFJK earnings history

Current Revenue
$0.0
Current Earnings
$920.5k
Current Profit Margin
0%

AFJK Return on Equity

Current Company
-25.3%
Current Industry
109.1%
Current Market
13.5%
AFJK's Return on Equity (-25.3%)... subscribe to Premium to read more.
High Return on Equity Performance

AFJK Return on Assets

Current Company
3.2%
Current Industry
-2.6%
AFJK is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AFJK announces earnings.

AFJK Return on Capital Employed

Current Company
10.49%
Current Industry
0%

AFJK vs Shell Company Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AFJK$920.55k$920.55k-30.43%$0.16
RFAI$2.44M$2.44M-52.63%$0.18
RDAC$1.33M$1.33MN/A-$0.12
DTSQ$1.35M$1.39MN/A-$0.13
QETA-$456.92k-$600.77kN/A-$0.16
View Top Shell Company Stocks

AFJK earnings dates

Next earnings date
Aug 12, 2026

Aimei Health Technology Co Earnings Reports & History FAQ

What were Aimei Health Technology Co's earnings last quarter?

Aimei Health Technology Co (NASDAQ: AFJK) reported Q1 2026 earnings per share (EPS) of $0.01, up 66.67% year over year. Total AFJK earnings for the quarter were $45.44 thousand. In the same quarter last year, Aimei Health Technology Co's earnings per share (EPS) was $0.03.

If you're new to stock investing, here's how to buy Aimei Health Technology Co stock.

When does Aimei Health Technology Co report earnings?

The next AFJK earnings call is Aug 12, 2026. Add AFJK to your watchlist to be reminded of Aimei Health Technology Co's next earnings date.

What was AFJK's earnings growth in the past year?

As of Aimei Health Technology Co's earnings date in Q3 2026, Aimei Health Technology Co's earnings has grown -30.43% year over year. This is 32.28 percentage points lower than the US Shell Companies industry earnings growth rate of 1.84%. AFJK earnings in the past year totalled $920.55 thousand.

Is Aimei Health Technology Co profitable or losing money?

As of the last Aimei Health Technology Co earnings report, Aimei Health Technology Co is currently profitable. Aimei Health Technology Co's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $920.55 thousand, a 53.54% decrease year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.